DIC Past Earnings Performance
Past criteria checks 0/6
DIC's earnings have been declining at an average annual rate of -65.2%, while the Chemicals industry saw earnings growing at 9.6% annually. Revenues have been growing at an average rate of 9.5% per year.
Key information
-65.2%
Earnings growth rate
-65.2%
EPS growth rate
Chemicals Industry Growth | 12.4% |
Revenue growth rate | 9.5% |
Return on equity | -6.6% |
Net Margin | -2.5% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How DIC makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 1,064,784 | -26,467 | 158,731 | 17,189 |
30 Jun 24 | 1,062,266 | -34,438 | 157,710 | 17,189 |
31 Mar 24 | 1,039,287 | -44,532 | 153,196 | 17,189 |
31 Dec 23 | 1,038,736 | -39,857 | 151,244 | 17,189 |
30 Sep 23 | 1,040,668 | -2,955 | 149,661 | 15,144 |
30 Jun 23 | 1,048,101 | 4,217 | 147,084 | 15,144 |
31 Mar 23 | 1,058,480 | 12,103 | 147,067 | 15,144 |
31 Dec 22 | 1,054,201 | 17,610 | 144,395 | 15,144 |
30 Sep 22 | 1,034,688 | 6,886 | 144,141 | 13,503 |
30 Jun 22 | 984,997 | 2,727 | 139,589 | 13,503 |
31 Mar 22 | 916,075 | 1,572 | 128,877 | 13,503 |
31 Dec 21 | 855,379 | 4,365 | 120,922 | 13,503 |
30 Sep 21 | 802,757 | 14,605 | 116,853 | 12,029 |
30 Jun 21 | 749,268 | 18,927 | 108,806 | 12,029 |
31 Mar 21 | 709,830 | 18,825 | 105,311 | 12,029 |
31 Dec 20 | 701,223 | 13,233 | 105,101 | 12,029 |
30 Sep 20 | 706,289 | 19,086 | 105,654 | 12,505 |
30 Jun 20 | 727,302 | 20,704 | 107,748 | 12,505 |
31 Mar 20 | 759,515 | 22,803 | 111,132 | 12,505 |
31 Dec 19 | 768,568 | 23,500 | 111,532 | 12,505 |
30 Sep 19 | 781,337 | 27,913 | 111,823 | 12,923 |
30 Jun 19 | 791,724 | 30,253 | 113,220 | 12,923 |
31 Mar 19 | 800,009 | 29,920 | 113,665 | 12,923 |
31 Dec 18 | 805,498 | 32,028 | 114,340 | 12,923 |
30 Sep 18 | 806,865 | 25,926 | 116,216 | 12,427 |
30 Jun 18 | 805,475 | 36,068 | 116,155 | 12,427 |
31 Mar 18 | 796,614 | 37,174 | 115,681 | 12,427 |
31 Dec 17 | 789,427 | 38,603 | 114,708 | 12,427 |
30 Sep 17 | 775,233 | 44,608 | 115,403 | 11,206 |
30 Jun 17 | 756,483 | 35,238 | 112,912 | 11,206 |
31 Mar 17 | 752,220 | 36,740 | 113,031 | 11,206 |
31 Dec 16 | 751,438 | 34,767 | 114,155 | 11,206 |
30 Sep 16 | 763,088 | 39,678 | 114,805 | 12,163 |
30 Jun 16 | 788,074 | 39,078 | 119,245 | 12,163 |
31 Mar 16 | 807,640 | 35,772 | 120,343 | 12,163 |
31 Dec 15 | 819,999 | 37,394 | 121,662 | 12,163 |
30 Sep 15 | 831,976 | 31,750 | 134,991 | 0 |
30 Jun 15 | 831,313 | 30,160 | 133,467 | 0 |
31 Mar 15 | 829,101 | 28,542 | 132,215 | 0 |
31 Dec 14 | 830,078 | 25,194 | 131,208 | 0 |
31 Dec 13 | 878,947 | 27,798 | 133,591 | 0 |
Quality Earnings: DPN is currently unprofitable.
Growing Profit Margin: DPN is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: DPN is unprofitable, and losses have increased over the past 5 years at a rate of 65.2% per year.
Accelerating Growth: Unable to compare DPN's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: DPN is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (7.2%).
Return on Equity
High ROE: DPN has a negative Return on Equity (-6.6%), as it is currently unprofitable.